Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Intersouth Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 165
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 72
Rounds per year 4.12
Lead investments 18
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.56
Exits 37
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Enterprise Software
  • Medical
Summary

In 1984 was created Intersouth Partners, which is appeared as VC. The leading representative office of defined VC is situated in the Durham. The venture was found in North America in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Biolex Therapeutics, 480 Biomedical, MicroCHIPS We can highlight the next thriving fund investment areas, such as Enterprise Software, Information Technology.

The overall number of key employees were 2.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 7-12 deals per year. The increased amount of exits for fund were in 2010. Opposing the other organizations, this Intersouth Partners works on 7 percentage points less the average amount of lead investments. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies. The average startup value when the investment from Intersouth Partners is 1-5 millions dollars. The important activity for fund was in 2007. Despite it in 2019 the fund had an activity.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Intersouth Partners, startups are often financed by Harbert Growth Partners, Alliance Technology Ventures, Skyline Ventures. The meaningful sponsors for the fund in investment in the same round are Skyline Ventures, Noro-Moseley Partners, H.I.G. Capital. In the next rounds fund is usually obtained by Grotech Ventures, The Aurora Funds, TVM Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Intersouth Partners:
Typical Co-investors
Intersouth Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Intersouth Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Lyra Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Wellness
$30M29 Jan 2020 Massachusetts, United States

Lyra Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Wellness
$29M26 Sep 2018 Massachusetts, United States

Azalea Health

Health Care
Information Technology
Software
$10M15 Jul 2016 Atlanta, Georgia, United States

480 Biomedical

Biotechnology
Medical
Medical Device
$11M01 Jun 2015 Massachusetts, United States

Vascular Pharmaceuticals

Biotechnology
Diabetes
Health Care
$9M20 Mar 2015 North Carolina, United States

CSA Medical

Biotechnology
Health Care
Medical Device
$16M22 Dec 2013 Maryland, United States

Advanced Animal Diagnostics

Biotechnology
Health Diagnostics
Veterinary
$6M10 Apr 2013 North Carolina, United States

Applied Genetics Technologies Corporation

Biotechnology
Genetics
Health Care
Pharmaceutical
$37M19 Nov 2012 Gainesville, Florida, United States

Enterprise Software
Information Technology
IT Management
Software
$25M09 Oct 2012 Austin, Texas, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Intersouth Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 165
Average round size 13M
Rounds per year 4.12
Peak activity year 2007
Lead investments 18
Follow on index 0.56
Exits 37
Group Appearance index 0.93

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Lyra Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Wellness
$30M29 Jan 2020 Massachusetts, United States

Lyra Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Wellness
$29M26 Sep 2018 Massachusetts, United States

Azalea Health

Health Care
Information Technology
Software
$10M15 Jul 2016 Atlanta, Georgia, United States

480 Biomedical

Biotechnology
Medical
Medical Device
$11M01 Jun 2015 Massachusetts, United States

Vascular Pharmaceuticals

Biotechnology
Diabetes
Health Care
$9M20 Mar 2015 North Carolina, United States

CSA Medical

Biotechnology
Health Care
Medical Device
$16M22 Dec 2013 Maryland, United States

Advanced Animal Diagnostics

Biotechnology
Health Diagnostics
Veterinary
$6M10 Apr 2013 North Carolina, United States

Applied Genetics Technologies Corporation

Biotechnology
Genetics
Health Care
Pharmaceutical
$37M19 Nov 2012 Gainesville, Florida, United States

Enterprise Software
Information Technology
IT Management
Software
$25M09 Oct 2012 Austin, Texas, United States
Crunchbase icon

Content report

The following text will be sent to our editors: